Using white blood cells to fight liver cancer

A new project, looking at the effect of blood containing anti-tumour activating cells on liver cancer, has been funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership.The number of people affected by liver cancer is increasing, with 4,000 new cases being diagnosed each year. Sadly, many of these patients are...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news